Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Androgen Signaling in Metastatic Bone Disease
Dushyanthy Arumugam
, Sudeh Izadmehr
,
Alice C. Levine
CTSA ConduITS - Institutes for Translational Sciences
Icahn School of Medicine at Mount Sinai
KL2
Medicine - Hematology and Medical Oncology
Medicine
Medicine - Endocrinology, Diabetes and Bone Disease
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Androgen Signaling in Metastatic Bone Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Androgen Signaling
100%
Prostate Cancer
100%
Metastatic Bone Disease
100%
Bone Metastasis
80%
Solid Tumors
40%
Androgens
40%
Prostate Cancer Cells
40%
Androgen Deprivation Therapy
40%
Novel Therapeutics
20%
Androgen Receptor
20%
Angiogenesis
20%
Wnt Signaling
20%
Promoting Growth
20%
Advanced Disease
20%
Multi-step Process
20%
Castration-resistant Prostate Cancer
20%
Cancer Growth
20%
Epithelial-to-mesenchymal Transition
20%
Osteoblast
20%
Osteolysis
20%
Therapeutic Targeting
20%
Androgen Synthesis
20%
Receptor Overexpression
20%
Osteolytic Metastasis
20%
Androgen Receptor Splice Variant
20%
Castration Resistance
20%
Bone-targeting
20%
Androgen Receptor mutation
20%
Medicine and Dentistry
Androgen
100%
Prostate Cancer
100%
Bone Disease
100%
Androgen Receptor
85%
Bone Metastasis
71%
Solid Malignant Neoplasm
28%
Cancer Cell
28%
Signal Transduction
28%
Androgen Deprivation Therapy
28%
Angiogenesis
14%
Cancer Growth
14%
Secretion (Process)
14%
Upregulation
14%
Mesenchymal-Epithelial Transition
14%
Osteolysis
14%
Morbidity
14%
Osteoblast
14%
Castration Resistant Prostate Cancer
14%
Wnt Signaling
14%
Androgen Synthesis
14%
Diseases
14%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Cancer Cell
33%
Signal Transduction
33%
Upregulation
16%
Secretion (Process)
16%
Angiogenesis
16%
Wnt Signaling Pathway
16%
Mesenchymal-Epithelial Transition
16%
Osteolysis
16%
Osteoblast
16%
Androgen Synthesis
16%
Morbidity
16%